Regulatory & Legal
EMA: CHMP adopted a positive opinion for Intrarosa (prasterone) 6.5 mg pessary from Endoceutics Ltd.
EMA: CHMP adopted a positive opinion for Intrarosa (prasterone) 6.5 mg pessary from Endoceutics Ltd. Intrarosa is intended for the treatment of vulvar and vaginal atrophy in postmenopausal women having moderate to severe symptoms. (ATC code: to be determined). The EC Decision will follow soon.
In an unexpected move, just before the end of 2011, ...
Improving expenditure efficiency has been, for a ver...
Your Portal Link to Mass Media Universe.
Valuable Quarterly Romanian Market Analysis.
Ask the analyst
Tailor-made advice for you